UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Endocrine-related cancer, ISSN 1351-0088, 3/2010, Volume 17, Issue 1, pp. R53 - R73
Review | Oncology | Endocrinology & Metabolism | Life Sciences & Biomedicine | Science & Technology | Humans | Digestive System Neoplasms - radiotherapy | Antineoplastic Agents - therapeutic use | Yttrium Radioisotopes - pharmacokinetics | Octreotide - pharmacokinetics | Digestive System Neoplasms - drug therapy | Gallium Radioisotopes - therapeutic use | Digestive System Neoplasms - diagnostic imaging | Neuroendocrine Tumors - diagnostic imaging | Receptors, Somatostatin - analysis | Organometallic Compounds - therapeutic use | Yttrium Radioisotopes - therapeutic use | Somatostatin - analogs & derivatives | Radiopharmaceuticals - pharmacokinetics | Octreotide - analogs & derivatives | Organometallic Compounds - pharmacokinetics | Treatment Outcome | Clinical Trials as Topic | Combined Modality Therapy | Indium Radioisotopes - pharmacokinetics | Positron-Emission Tomography - methods | Octreotide - therapeutic use | Somatostatin - pharmacokinetics | Peptides, Cyclic - pharmacokinetics | Neuroendocrine Tumors - radiotherapy | Animals | Organotechnetium Compounds - pharmacokinetics | Positron-Emission Tomography - standards | Receptors, Somatostatin - drug effects | Gallium Radioisotopes - pharmacokinetics | Neuroendocrine Tumors - drug therapy | Peptides, Cyclic - therapeutic use | Quality of Life | Indium Radioisotopes - therapeutic use | Somatostatin - therapeutic use | Radiopharmaceuticals - therapeutic use | Index Medicus
Journal Article
Clinical cancer research, ISSN 1078-0432, 08/2009, Volume 15, Issue 16, pp. 5240 - 5249
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Neoplasms - metabolism | Receptors, Bombesin - agonists | Radioisotopes - pharmacokinetics | Tomography, Emission-Computed, Single-Photon - methods | Receptors, G-Protein-Coupled - metabolism | Humans | Transplantation, Heterologous | Receptors, G-Protein-Coupled - agonists | Gallium Radioisotopes - therapeutic use | Heterocyclic Compounds, 1-Ring - chemistry | Female | Bombesin - chemistry | Oligopeptides - chemistry | Radioisotopes - therapeutic use | Oligopeptides - pharmacokinetics | Cells, Cultured | Indium Radioisotopes - chemistry | Gallium Radioisotopes - chemistry | Indium Radioisotopes - pharmacokinetics | Positron-Emission Tomography - methods | Neoplasms - diagnostic imaging | Receptors, Bombesin - antagonists & inhibitors | Receptors, Bombesin - metabolism | Animals | Mice, Nude | Models, Biological | Receptors, G-Protein-Coupled - antagonists & inhibitors | Gallium Radioisotopes - pharmacokinetics | Indium Radioisotopes - therapeutic use | Mice | Drug Delivery Systems - methods | Radioisotopes - chemistry | Index Medicus
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 2016, Volume 58, pp. 41 - 51
Hematology, Oncology and Palliative Medicine | Oncology | Neuroendocrine neoplasm | Functional syndromes | Radiotherapy | Peptide receptor radionuclide therapy | Life Sciences & Biomedicine | Science & Technology | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Male | Radiopharmaceuticals - metabolism | Gallium Radioisotopes - therapeutic use | Gallium Radioisotopes - adverse effects | Time Factors | Organometallic Compounds - therapeutic use | Adult | Female | Registries | Receptors, Somatostatin - metabolism | Octreotide - analogs & derivatives | Neuroendocrine Tumors - metabolism | Organometallic Compounds - adverse effects | Kaplan-Meier Estimate | Proportional Hazards Models | Octreotide - adverse effects | Treatment Outcome | Octreotide - therapeutic use | Octreotide - metabolism | Remission Induction | Disease-Free Survival | Neuroendocrine Tumors - radiotherapy | Gallium Radioisotopes - metabolism | Organometallic Compounds - metabolism | Neuroendocrine Tumors - mortality | Radiopharmaceuticals - adverse effects | Germany | Radiopharmaceuticals - therapeutic use | Peptides | Care and treatment | Tumors | Index Medicus
Journal Article
Clinical nuclear medicine, ISSN 0363-9762, 01/2017, Volume 42, Issue 1, pp. e29 - e34
adrenocortical cancer | CXCR4 | in vivo imaging | chemokine receptor | PET/CT | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Radioisotopes - therapeutic use | Humans | Middle Aged | Adrenal Cortex Neoplasms - diagnostic imaging | Male | Radiotherapy | Patient Selection | Receptors, CXCR4 - metabolism | Peptides, Cyclic | Positron Emission Tomography Computed Tomography | Adrenocortical Carcinoma - radiotherapy | Adrenocortical Carcinoma - diagnostic imaging | Adrenocortical Carcinoma - metabolism | Radionuclide Imaging | Gallium Radioisotopes | Adrenal Cortex Neoplasms - radiotherapy | Adult | Coordination Complexes | Female | Aged | Lutetium - therapeutic use | Yttrium Radioisotopes - therapeutic use | Adrenal Cortex Neoplasms - metabolism | Peptides - therapeutic use | Index Medicus
Journal Article
The Journal of nuclear medicine (1978), ISSN 0161-5505, 11/2015, Volume 56, Issue 11, pp. 1697 - 1705
PSMA | Dosimetry | Positron emission tomography | Prostate cancer | PET/CT | Prostate-specific membrane antigen | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Prostatic Neoplasms - metabolism | Prostatic Neoplasms - radiotherapy | Dipeptides - therapeutic use | Theranostic Nanomedicine | Humans | Middle Aged | Male | Positron-Emission Tomography | Salivary Glands - diagnostic imaging | Tissue Distribution | Kidney - metabolism | Gallium Radioisotopes - therapeutic use | Image Processing, Computer-Assisted | Kidney - diagnostic imaging | Heterocyclic Compounds, 1-Ring - therapeutic use | Organometallic Compounds - therapeutic use | Prostatic Neoplasms - diagnostic imaging | Adult | Radiometry | Prostate-Specific Antigen - chemistry | Salivary Glands - metabolism | Radiopharmaceuticals - therapeutic use | Antigens | Nuclear medicine | Kidneys | Ligands | Tissues | Tumors | Index Medicus
Journal Article
6.
Full Text
68Ga/177Lu-NeoBOMB1, a novel radiolabeled GRPR antagonist for theranostic use in oncology
The Journal of nuclear medicine (1978), ISSN 0161-5505, 02/2017, Volume 58, Issue 2, pp. 293 - 299
Gastrin releasing peptide receptor | Dosimetry | Biodistribution | GRPR antagonist | Cancer theranostics | Humans | Male | Treatment Outcome | Gallium Radioisotopes - chemistry | Neoplasms, Experimental - radiotherapy | Receptors, Bombesin - antagonists & inhibitors | Radiopharmaceuticals - chemical synthesis | Neoplasms, Experimental - diagnostic imaging | Isotope Labeling - methods | Animals | Gallium Radioisotopes - therapeutic use | Theranostic Nanomedicine - methods | Mice, Nude | Cell Line, Tumor | Mice | Bombesin - therapeutic use | Neoplasms, Experimental - metabolism | Molecular Targeted Therapy - methods | Radiopharmaceuticals - therapeutic use | Index Medicus
Journal Article
Bioconjugate chemistry, ISSN 1043-1802, 05/2002, Volume 13, Issue 3, pp. 530 - 541
Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Chemistry, Organic | Life Sciences & Biomedicine | Biochemical Research Methods | Chemistry, Multidisciplinary | Science & Technology | Pancreatic Neoplasms - metabolism | Tomography, Emission-Computed, Single-Photon | Cells, Cultured - diagnostic imaging | Octreotide - pharmacokinetics | Tissue Distribution | Gallium Radioisotopes - therapeutic use | Heterocyclic Compounds - chemistry | Female | Receptors, Somatostatin - metabolism | Peptide Fragments - metabolism | Radiopharmaceuticals - pharmacokinetics | Octreotide - analogs & derivatives | Drug Stability | Liver - metabolism | Pancreatic Neoplasms - radiotherapy | Rats | Heterocyclic Compounds - metabolism | Indium Radioisotopes - pharmacokinetics | Octreotide - therapeutic use | Peptide Fragments - chemistry | Animals | Mice, Nude | Gallium Radioisotopes - pharmacokinetics | Protein Binding | Indium Radioisotopes - therapeutic use | Ligands | Cells, Cultured - metabolism | Mice | Tomography, Emission-Computed | In Vitro Techniques | Radiopharmaceuticals - therapeutic use | Index Medicus
Journal Article
European journal of nuclear medicine and molecular imaging, ISSN 1619-7070, 2/2012, Volume 39, Issue S1, pp. 126 - 138
Molecular imaging | Angiogenesis | RGD peptides | Medicine & Public Health | Orthopedics | Oncology | Nuclear Medicine | Imaging / Radiology | Cardiology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Neoplasms - metabolism | Peptides | Polyethylene Glycols | Humans | Tomography, Emission-Computed, Single-Photon | Neoplasms - blood supply | Technetium | Neoplasms - diagnostic imaging | Integrins - metabolism | Neovascularization, Pathologic - diagnostic imaging | Oligopeptides - therapeutic use | Peptides, Cyclic | Galactose - analogs & derivatives | Angiogenesis Inhibitors - therapeutic use | Gallium Radioisotopes | Neoplasms - radiotherapy | Neovascularization, Pathologic - metabolism | Neovascularization, Pathologic - radiotherapy | Copper Radioisotopes | Radiopharmaceuticals - therapeutic use | Angiogenesis inhibitors | Integrins | Beer | Medical imaging | Drug therapy | Index Medicus
Journal Article
Bioconjugate chemistry, ISSN 1043-1802, 06/2019, Volume 30, Issue 6, pp. 1745 - 1753
Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Chemistry, Organic | Life Sciences & Biomedicine | Biochemical Research Methods | Chemistry, Multidisciplinary | Science & Technology | Exenatide - therapeutic use | Theranostic Nanomedicine | Heterocyclic Compounds, 1-Ring - pharmacokinetics | Insulinoma - diagnostic imaging | Humans | Positron-Emission Tomography | Gallium Radioisotopes - chemistry | Exenatide - chemistry | Animals | Gallium Radioisotopes - therapeutic use | Heterocyclic Compounds, 1-Ring - chemistry | HEK293 Cells | Gallium Radioisotopes - pharmacokinetics | Heterocyclic Compounds, 1-Ring - therapeutic use | Female | Insulinoma - radiotherapy | Exenatide - pharmacokinetics | Mice | Glucagon-Like Peptide-1 Receptor - analysis | Brushes | Intravenous administration | Peptides | Glucagon | DDE | Insulinoma | Radioactive tracers | Neutral endopeptidase | Accumulation | Image acquisition | Degradation | Synthesis | Cleavage | Nitrous oxide | Diagnosis | Localization | Glucagon-like peptide 1 | Radioactivity | Urine | Enzymes | Kidneys | Incubation | Membrane vesicles | Stability analysis | Radiation therapy | Metabolism | Endopeptidase | Affinity | Ligands | In vivo methods and tests | Neprilysin | Tumors | Index Medicus
Journal Article
Nuclear medicine and biology, ISSN 0969-8051, 2016, Volume 46, pp. 12 - 18
Radiology | Clonogenic assay | Radionuclide therapy | Auger electrons | Gallium-67 | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Prostatic Neoplasms - pathology | Gallium Radioisotopes - therapeutic use | Radiopharmaceuticals - chemistry | Breast Neoplasms - pathology | Humans | Cell Line, Tumor | Isotope Labeling | Male | DNA Damage | Cell Survival - radiation effects | Oxyquinoline - chemistry | Radiopharmaceuticals - therapeutic use | Prostate cancer | Health aspects | Analysis | Nuclear medicine | Gallium | Incubation | Toxicity | DNA damage | Radioisotopes | Cytotoxicity | Ethylenediaminetetraacetic acids | Biocompatibility | In vivo methods and tests | Chelating agents | Plasmid DNA | Damage | Prostate | Edetic acid | Deoxyribonucleic acid--DNA | Electrons | Augers | Cancer | Index Medicus
Journal Article
2013, 1. Aufl., Recent results in cancer research, ISBN 9783642279942, Volume 194, 567
eBook